Subtype
Female Reproductive System Neoplasm
CI-CAN-00000885Explore in graph →
Non-malignant1,633 active trials11 approved drugs139 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00000885Explore in graph →
Clinical trials
7,174 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06401265 | Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC) | completed | — | 8,000 | Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical FoundationOTHER | 1 | May 6, 2024 | clinicaltrials |
| NCT01832116 | 89Zr-MMOT PET Imaging in Pancreatic and Ovarian Cancer Patients(MMOT) | completed | Phase 1 | 11 | University Medical Center GroningenOTHER | 1 | May 3, 2024 |
| clinicaltrials |
| NCT02132858 | Genetic Mutations in Blood and Tissue Samples in Predicting Response to Treatment in Patients With Locally Advanced Rectal Cancer Undergoing Chemoradiation | completed | — | 43 | Fox Chase Cancer CenterOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT02864147 | Treatment of High-Grade Pre-Neoplastic Cervical Lesions (CIN 2/3) | completed | Phase 2 | 134 | Yale UniversityOTHER | 1 | May 2, 2024 | clinicaltrials |
| NCT06394258 | POSE - POs Surgery Endometrial Cancer(POSE) | completed | N/A | 30 | Fundacao ChampalimaudOTHER | 1 | May 1, 2024 | clinicaltrials |
| NCT04751799 | Virtual Reality: Influence on Satisfaction, Pain, and Anxiety in Patients Undergoing Colposcopy | completed | N/A | 247 | Ruhr University of BochumOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT05679141 | Clinical Correlation Between Self-collected and Physician-collected HPV Screening Kits | completed | — | 344 | Switch Health Solutions Inc.INDUSTRY | 1 | Apr 26, 2024 | clinicaltrials |
| NCT06385912 | Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer | completed | — | 1,090 | Tongji HospitalOTHER | 1 | Apr 26, 2024 | clinicaltrials |
| NCT04374760 | Increasing Cervical Cancer Screening Uptake Among Emergency Department Patients | completed | N/A | 1,116 | University of RochesterOTHER | 1 | Apr 24, 2024 | clinicaltrials |
| NCT03206645 | Unesbulin in Women With Ovarian Cancer Receiving Neoadjuvant Chemotherapy(PTC-001) | completed | Phase 1 | 27 | University of OklahomaOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT03837327 | Clinical Validation of the InterVenn Ovarian CAncer Liquid Biopsy(VOCAL) | completed | — | 1,025 | Venn Biosciences CorporationINDUSTRY | 4 | Apr 23, 2024 | clinicaltrials |
| NCT05378152 | Assessing the Benefit of Pipelle Biopsy in Patients With Postmenopausal Bleeding and an Atrophic-appearing Cavity | completed | N/A | 82 | Royal College of Surgeons, IrelandOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06379191 | The Efficacy of WeChat-based Multidisciplinary Full-course Nutritional Management Program | completed | N/A | 78 | Peking Union Medical College HospitalOTHER | 1 | Apr 23, 2024 | clinicaltrials |
| NCT06063343 | Evaluation of Safety, Tolerability, Pharmacokinetics, Food Effect and Interaction With Midazolam in Healthy Volunteers After Oral Single and Multiple Ascending Dosing of KAND145 | completed | Phase 1 | 50 | Novakand Pharma ABINDUSTRY | 1 | Apr 22, 2024 | clinicaltrials |
| NCT01088347 | Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer | completed | Phase 1 / Phase 2 | 9 | University Medical Center GroningenOTHER | 1 | Apr 19, 2024 | clinicaltrials |
| NCT01526655 | Robot Assisted Laparoscopic Hysterectomy vs. Abdominal Hysterectomy in Endometrial Cancer | completed | N/A | 50 | University Hospital, LinkoepingOTHER | 1 | Apr 18, 2024 | clinicaltrials |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | completed | — | 17,667 | Sanguine BiosciencesINDUSTRY | 1 | Apr 18, 2024 | clinicaltrials |
| NCT01953094 | Overlooked Population at Risk for AIN. | completed | N/A | 355 | Sunnybrook Health Sciences CentreOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT06366997 | Diagnosis of Epithelial Ovarian Cancer Using Ovarian Cancer Score (OCS) Test | completed | — | 1,352 | Chongqing University Cancer HospitalOTHER | 1 | Apr 16, 2024 | clinicaltrials |
| NCT05414097 | Finding Barriers and Designing Solutions to Promote Women s Cancer Screening in South Africa(FIND) | completed | — | 348 | UNC Lineberger Comprehensive Cancer CenterOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT06365450 | Breast and Cervical Cancer Education Program(OCEAP) | completed | N/A | 60 | Johns Hopkins UniversityOTHER | 1 | Apr 15, 2024 | clinicaltrials |
| NCT03958357 | Post Market Clinical Follow-up Study Venezia | completed | — | 41 | Nucletron Operations BVINDUSTRY | 3 | Apr 12, 2024 | clinicaltrials |
| NCT03921658 | The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer | completed | — | 255 | University of MinnesotaOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT04898842 | Feasibility Study of a 4 Stage Bowel Obstruction Cancer Diet(BOUNCED) | completed | N/A | 30 | Royal Surrey County Hospital NHS Foundation TrustOTHER | 1 | Apr 10, 2024 | clinicaltrials |
| NCT04298827 | Gyn Onc Prehab Study | completed | N/A | 83 | St. Louis UniversityOTHER | 1 | Apr 8, 2024 | clinicaltrials |
| NCT03490669 | Study to Evaluate Safety, PK, PD, Immunogenicity & Antitumor Activity of MSC-1 in Patients With Adv Solid Tumors | completed | Phase 1 | 41 | AstraZenecaINDUSTRY | 3 | Apr 5, 2024 | clinicaltrials |
| NCT00445965 | Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer | completed | Phase 2 | 78 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Apr 4, 2024 | clinicaltrials |
| NCT02797600 | Community Awareness, Resources and Education (CARE II) Project: Project 1 | completed | — | 285 | Ohio State University Comprehensive Cancer CenterOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT06342934 | Radiomics and Machine Learning in the Diagnosis of Ovarian Masses(Multi-AROMA) | completed | — | 1,000 | Fondazione IRCCS Istituto Nazionale dei Tumori, MilanoOTHER | 1 | Apr 2, 2024 | clinicaltrials |
| NCT03940196 | Effect of Tumor Treating Fields (TTFields, 200 kHz) Concomitant With Weekly Paclitaxel for the Treatment of Recurrent Ovarian Cancer (ENGOT-ov50 / GOG-3029 / INNOVATE-3) | completed | Phase 3 | 540 | NovoCure Ltd.INDUSTRY | 13 | Mar 29, 2024 | clinicaltrials |
| NCT06049693 | Iron Prehabilitation in Endometrial Cancer(IROGYN) | completed | Phase 4 | 156 | National and Kapodistrian University of AthensOTHER | 1 | Mar 29, 2024 | clinicaltrials |
| NCT03329950 | A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies | completed | Phase 1 | 132 | Celldex TherapeuticsINDUSTRY | 1 | Mar 28, 2024 | clinicaltrials |
| NCT05375136 | A Study of Lenvatinib in Combination With Pembrolizumab in Korean Patients | completed | — | 135 | Eisai Korea Inc.INDUSTRY | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06328491 | Erdafitinib in Metastatic Steroid-cell Ovarian Cancer | completed | N/A | 1 | University Health Network, TorontoOTHER | 1 | Mar 25, 2024 | clinicaltrials |
| NCT06318702 | The Effect of Constructivist Learning Model Based Gynecological Cancer Education | completed | N/A | 107 | Kastamonu UniversityOTHER | 1 | Mar 20, 2024 | clinicaltrials |
| NCT00667563 | Vaccine Therapy in Preventing HPV in HIV-Positive Women in India | completed | Phase 1 | 150 | AIDS Malignancy ConsortiumNETWORK | 1 | Mar 19, 2024 | clinicaltrials |
| NCT01886066 | Accuracy of Sentinel Lymph Node Biopsy in Nodal Staging of High Risk Endometrial Cancer(EndoSLN) | completed | N/A | 156 | University Health Network, TorontoOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03339843 | Multiorgan Metabolic Imaging Response Assessment of Abemaciclib(MiMe-A) | completed | Phase 2 | 85 | Jules Bordet InstituteOTHER | 2 | Mar 15, 2024 | clinicaltrials |
| NCT03629886 | Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study | completed | Phase 4 | 6,051 | GlaxoSmithKlineINDUSTRY | 1 | Mar 15, 2024 | clinicaltrials |
| NCT03856437 | A Message Framing Intervention for Increasing Parental Acceptance of Human Papillomavirus Vaccination | completed | N/A | 1,170 | University of Maryland, College ParkOTHER | 1 | Mar 15, 2024 | clinicaltrials |
| NCT00250783 | Pre-Clinical Models in Gynecological Tumors A Tissue Repository | completed | — | 26 | University of New MexicoOTHER | 1 | Mar 12, 2024 | clinicaltrials |
| NCT01214330 | Clinician-Collected Versus Patient-Collected Cervical Pap Smears(SoloPaP) | completed | N/A | 150 | Mike O'Callaghan Military HospitalFED | 1 | Mar 12, 2024 | clinicaltrials |
| NCT03189446 | Vaginal Cuff Brachytherapy Followed by Chemotherapy in Endometrial Cancer | completed | Phase 2 | 39 | University of OklahomaOTHER | 1 | Mar 8, 2024 | clinicaltrials |
| NCT03665285 | A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors | completed | Phase 1 / Phase 2 | 109 | NextCure, Inc.INDUSTRY | 1 | Mar 8, 2024 | clinicaltrials |
| NCT04551950 | Bintrafusp Alfa Combination Therapy in Participants With Cervical Cancer (INTR@PID 046) | completed | Phase 1 | 25 | EMD Serono Research & Development Institute, Inc.INDUSTRY | 3 | Mar 8, 2024 | clinicaltrials |
| NCT00020267 | Vaccine Therapy in Treating Patients With Metastatic Cancer | completed | Phase 1 | — | National Cancer Institute (NCI)NIH | 1 | Mar 4, 2024 | clinicaltrials |
| NCT01865929 | Minimally Invasive Benign Hysterectomy | completed | N/A | 124 | Region SkaneOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT01001910 | Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer | completed | Phase 2 | 22 | Albert Einstein College of MedicineOTHER | 1 | Feb 28, 2024 | clinicaltrials |
| NCT03012620 | Secured Access to Pembrolizumab for Patients With Selected Rare Cancer Types(AcSé) | completed | Phase 2 | 334 | UNICANCEROTHER | 1 | Feb 28, 2024 | clinicaltrials |
Data updated 24 days agoSource updated May 6, 2024source: clinicaltrials